EyeGate Pharmaceuticals, Inc.
Compositions and Methods for Treatment of Ocular Conditions

Last updated:

Abstract:

The present disclosure relates to compositions and methods for treating ocular conditions or diseases with low or poorly water-soluble therapeutics incorporated into a hydrogel. In particular, the disclosure relates to non-blurring, therapeutic-containing hydrogel compositions that have an extended contact time on the eye and do not interfere with wound healing.

Status:
Application
Type:

Utility

Filling date:

22 Mar 2021

Issue date:

23 Sep 2021